AXDX Accelerate Diagnostics Inc
2,170
$0.8341
$0.0709
(7.83%)
| Watchers | 2,170 |
| 52-Wk Low | $0.73 |
| 52-Wk High | $11.90 |
| Market Cap | $19.61M |
| Volume | 40,647.00 |
| 52-Wk High | $11.90 |
| 52-Wk Low | $0.73 |
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsPR Newswire • about 23 hours ago
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results PR Newswire TUCSON, Ariz., May 8, 2024...
Share to Feed
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. PR Newswire TUCSON, Ariz., May 2, 2024 TUCSON...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX - Get Free Report) CEO Jack Phillips sold 15,887 shares of the company's stock in a transaction on Thursday, April 4th. The stock was sold at an average...
Analysts at StockNews.com assumed coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on...
William Blair restated their outperform rating on shares of Accelerate Diagnostics (NASDAQ:AXDX - Free Report) in a research note published on Tuesday, RTT News reports. William Blair also issued...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Staar Surgical (STAA Research Report), DarioHealth (DRIO Rese...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Accelerate Diagnostics (AXDX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Accelerate Diagnostics has positioned its...
Analysts at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX Get Free Report) in a research note issued to investors on Wednesday. The firm set a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth...